AstraZeneca Pharma India Ltd. — Board/Management Information 2023

Dec 21, 2023

==> picture [512 x 78] intentionally omitted <==

December 21, 2023

The Manager – Listing BSE Limited , 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai – 400 001

The Manager – Listing National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051

Dear Sir(s),

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure - - Requirements) Regulations, 2015 Appointment of Additional Director (Non Executive)

Ref: Scrip Code - BSE: 506820 / NSE: ASTRAZEN

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company have approved the appointment of Ms. Sylvia Lorena Varela Ramon (DIN: 10410837), as an Additional Director (Non-Executive) of the Company with effect from December 21, 2023.

In this regard, please find the details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 attached herewith as Annexure – A.

We request you to please take the same on record.

Thanking you,

For AstraZeneca Pharma India Limited

MANASA Digitally signed by MANASA RAMA RAMA Date: 2023.12.21 15:46:01 +05'30' Manasa. R Company Secretary

==> picture [453 x 64] intentionally omitted <==

==> picture [512 x 78] intentionally omitted <==

Annexure - A

Appointment of Ms. Sylvia Lorena Varela Ramon (DIN: 10410837) as an Additional Director (Non-Executive) of the Company

Sl. No		Particulars	Details
1		Reason for change viz. appointment, ~~resignation,~~ ~~removal, death or otherwise~~;	Appointment of Ms. Sylvia Lorena Varela Ramon (DIN: 10410837) as an Additional Director (Non- Executive).
2		Date of appointment and term of appointment	Effective : December 21, 2023 Term of appointment – Not Applicable
3		Brief Profile	Ms. Sylvia Varela is Vice President for Asia Area in AstraZeneca. Based in Singapore, she leads AstraZeneca’s commercial operations in Korea, Taiwan, Singapore, Malaysia, Philippines, Indonesia, Thailand, Vietnam and India. She has over 25 years experience in the pharmaceutical industry. With AstraZeneca, she was previously Vice President for Latin America, Country President for Mexico and Country President for Colombia. Prior to that she held commercial leadership positions with Pfizer.
4		Disclosure of relationships between directors	None

==> picture [453 x 64] intentionally omitted <==